Skip to main content

Advertisement

Open Peer Review Reports for: FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
17 Dec 2018 Submitted Original manuscript
3 Jan 2019 Author responded Author comments - Lana McClements
Resubmission - Version 2
3 Jan 2019 Submitted Manuscript version 2
14 Feb 2019 Reviewed Reviewer Report - Jean-Philippe Brosseau
24 Feb 2019 Reviewed Reviewer Report - Min Zheng
26 Feb 2019 Author responded Author comments - Lana McClements
Resubmission - Version 3
26 Feb 2019 Submitted Manuscript version 3
13 Mar 2019 Author responded Author comments - Lana McClements
Resubmission - Version 4
13 Mar 2019 Submitted Manuscript version 4
Publishing
20 Mar 2019 Editorially accepted
11 Apr 2019 Article published 10.1186/s12885-019-5500-0

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement